Novartis lung drug has similar efficacy to rival
Swiss drugmaker Novartis AG experimental lung drug NVA237 helps patients with a life threatening respiratory disease in a similar way to a rival drug from Pfizer and Boehringer Ingelheim, a late-stage study showed.
View full post on Yahoo! Health News
drug, efficacy, Lung, Novartis, Rival, similar